SCHEMBL8858892

SCHEMBL8858892

CSc1cn2cccc2c(SC)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 6/20 0.36
NPC1 O15118 4/20 0.33
ALDH1A1 P00352 4/20 0.33
RAB9A P51151 4/20 0.33
KDM4E B2RXH2 3/20 0.33
TP53 P04637 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
HSD17B10 Q99714 2/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NFKB1 P19838 2/20 0.32
NFKB2 Q00653 2/20 0.32
RELA Q04206 2/20 0.32
GAA P10253 1/20 0.32
PTGS2 P35354 1/20 0.31
PKM P14618 1/20 0.30
ALDH1A2 O94788 1/20 0.30
ALDH1A3 P47895 1/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14725911 0.82 GRM5 (0.49) GRM5NPC1ALDH1A1RAB9AKDM4E
SCHEMBL27122183 0.79 GRM5 (0.34) GRM5NPC1ALDH1A1RAB9AKDM4E
SCHEMBL20053810 0.70 PTGS1 (0.47) NPC1ALDH1A1RAB9AKDM4ETP53
SCHEMBL26753502 0.66 ALOX15 (0.35) ALDH1A1KDM4EHSD17B10HPGDGAA
SCHEMBL25065096 0.63 RAB9A (0.42) NPC1ALDH1A1RAB9AKDM4ETP53
SCHEMBL13153126 0.62 GRM5 (0.54) GRM5NPC1ALDH1A1RAB9AKDM4E
SCHEMBL15754794 0.59 GRM5 (0.55) GRM5NPC1ALDH1A1RAB9AKDM4E
SCHEMBL9517797 0.59 NPC1 (0.44) NPC1ALDH1A1RAB9AKDM4ETP53
SCHEMBL25150638 0.58 APP (0.32)
SCHEMBL26650790 0.58 ADORA1 (0.38) GRM5NPC1ALDH1A1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997003055-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR INHIBITING REPLICATION OF RETROVIRUSES AND FOR INHIBITING TUMOR PROMOTER INITIATED TRANSCRIPTION SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1997-01-30 WO disclosed